Are you struggling with the persistent challenge of venous ulcers?
As a healthcare professional or medical product distributor, you understand the complexities of managing these chronic wounds. Venous ulcers, often a result of chronic venous insufficiency, can be frustrating for both patients and caregivers.
But what if there was a solution that could transform the way we approach wound care for venous stasis ulcers?
Ideal for: Wet venous ulcers with heavy exudate
Features: Rapid absorption, excellent for controlling moisture
Ideal for: Dry venous ulcers or those with minimal exudation
Features: Provides moisture to dry wounds, supports autolytic debridement
Ideal for: Large, wet venous ulcers
Features: Easy application, especially for hard-to-reach areas
Ideal for: Surgical incisions or wounds requiring additional protection
Features: Combines the benefits of Dermlin with the convenience of a pre-prepared dressing
Dermlin's special structure allows for efficient absorption of wound exudate, maintaining an optimal moisture balance crucial for healing.
The product's composition creates an environment inhospitable to bacterial growth, reducing the risk of wound infection.
By providing an ideal wound bed, Dermlin promotes rapid tissue regeneration, significantly reducing healing times.
The unique chemical constitution of Dermlin supports the formation of healthier tissue, minimizing scarring.
With various formulations available, Dermlin can be tailored to different wound types and stages.
Patient: 87-year-old male
Condition: Deep vein valve insufficiency of both legs, venous leg ulcer
Comorbidities: Oronary heart disease (CHD), secondary protein-energy malnutrition, anemia of chronic disease
Outcome: Complete wound closure achieved in 8 weeks, amputation avoided.
Treatment Protocol:
Product: Dermlin Wound Healing Powder
Dosage: 2 bottles
Duration: 56 days (October 3, 2010 to November 30, 2010)
Result: Complete healing achieved
This case exemplifies the powerful healing potential of Dermlin, even in complex cases with multiple comorbidities. The complete resolution of a venous ulcer in less than two months is a testament to Dermlin's effectiveness.
Clinical results speak for themselves, with rapid healing times and improved patient outcomes.
By accelerating healing and reducing complications, Dermlin can significantly lower overall treatment costs.
Less frequent dressing changes and reduced wound odor improve patient quality of life.
Suitable for various wound types and stages, simplifying inventory management.
Minimal training required, saving time for healthcare professionals.
Developed using cutting-edge biotech research, ensuring a reliable and effective product.
As the global population ages and chronic conditions become more prevalent, the demand for effective venous ulcer treatments will only increase. By embracing innovative solutions like Dermlin, you position yourself at the forefront of wound care technology.
Yenssen's commitment to research and development ensures that Dermlin will continue to evolve, meeting the changing needs of patients and healthcare providers. By choosing Dermlin, you're not just selecting a product – you're investing in the future of wound care.
Don't let your patients or clients struggle with ineffective venous ulcer treatments any longer. Discover the Dermlin difference and transform your approach to wound care for venous stasis ulcers.
Contact Yenssen today to learn more about how Dermlin can revolutionize your wound care practice or enhance your product portfolio. Our team of experts is ready to provide you with detailed information, clinical data, and support to help you make an informed decision.
EN 
ES
PT
SV
DE
TR
FR
JA